These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21798846)

  • 1. NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.
    Al-Mayhani MT; Grenfell R; Narita M; Piccirillo S; Kenney-Herbert E; Fawcett JW; Collins VP; Ichimura K; Watts C
    Neuro Oncol; 2011 Aug; 13(8):830-45. PubMed ID: 21798846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
    Al-Mayhani TF; Heywood RM; Vemireddy V; Lathia JD; Piccirillo SGM; Watts C
    Neuro Oncol; 2019 Jun; 21(6):719-729. PubMed ID: 30590711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.
    Lama G; Mangiola A; Proietti G; Colabianchi A; Angelucci C; D' Alessio A; De Bonis P; Geloso MC; Lauriola L; Binda E; Biamonte F; Giuffrida MG; Vescovi A; Sica G
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):134-47. PubMed ID: 26792897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.
    Wang J; Svendsen A; Kmiecik J; Immervoll H; Skaftnesmo KO; Planagumà J; Reed RK; Bjerkvig R; Miletic H; Enger PØ; Rygh CB; Chekenya M
    PLoS One; 2011; 6(7):e23062. PubMed ID: 21829586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway.
    Nakano I; Joshi K; Visnyei K; Hu B; Watanabe M; Lam D; Wexler E; Saigusa K; Nakamura Y; Laks DR; Mischel PS; Viapiano M; Kornblum HI
    Neuro Oncol; 2011 Jun; 13(6):622-34. PubMed ID: 21558073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.
    Garcia JL; Perez-Caro M; Gomez-Moreta JA; Gonzalez F; Ortiz J; Blanco O; Sancho M; Hernandez-Rivas JM; Gonzalez-Sarmiento R; Sanchez-Martin M
    BMC Cancer; 2010 Aug; 10():454. PubMed ID: 20735813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.
    Svendsen A; Verhoeff JJ; Immervoll H; Brøgger JC; Kmiecik J; Poli A; Netland IA; Prestegarden L; Planagumà J; Torsvik A; Kjersem AB; Sakariassen PØ; Heggdal JI; Van Furth WR; Bjerkvig R; Lund-Johansen M; Enger PØ; Felsberg J; Brons NH; Tronstad KJ; Waha A; Chekenya M
    Acta Neuropathol; 2011 Oct; 122(4):495-510. PubMed ID: 21863242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
    Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
    Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
    Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
    PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1.
    Zhang R; Luo H; Wang S; Chen W; Chen Z; Wang HW; Chen Y; Yang J; Zhang X; Wu W; Zhang SY; Shen S; Dong Q; Zhang Y; Jiang T; Lu D; Zhao S; You Y; Liu N; Wang H
    Neuro Oncol; 2014 Nov; 16(11):1510-22. PubMed ID: 24951112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2.
    Maus F; Sakry D; Binamé F; Karram K; Rajalingam K; Watts C; Heywood R; Krüger R; Stegmüller J; Werner HB; Nave KA; Krämer-Albers EM; Trotter J
    PLoS One; 2015; 10(9):e0137311. PubMed ID: 26340347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
    Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
    Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
    Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 expression and prognostic impact in glioblastoma.
    Nduom EK; Wei J; Yaghi NK; Huang N; Kong LY; Gabrusiewicz K; Ling X; Zhou S; Ivan C; Chen JQ; Burks JK; Fuller GN; Calin GA; Conrad CA; Creasy C; Ritthipichai K; Radvanyi L; Heimberger AB
    Neuro Oncol; 2016 Feb; 18(2):195-205. PubMed ID: 26323609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
    Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
    Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.
    Colin C; Baeza N; Bartoli C; Fina F; Eudes N; Nanni I; Martin PM; Ouafik L; Figarella-Branger D
    Oncogene; 2006 May; 25(19):2818-26. PubMed ID: 16314830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
    Floyd DH; Kefas B; Seleverstov O; Mykhaylyk O; Dominguez C; Comeau L; Plank C; Purow B
    Neuro Oncol; 2012 Oct; 14(10):1215-26. PubMed ID: 22962413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.